The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Estrid V. S. Hogdall

Department of Pathology

Danish CancerBiobank

Herlev University Hospital

Copenhagen

Denmark

[email]@dadlnet.dk

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Department of Pathology, Danish CancerBiobank, Herlev University Hospital, Copenhagen, Denmark. 2010
  • Department of Virus, Hormones and Cancer, Institute of Cancer Epidemiology, Danish Cancer Society, Denmark. 2004 - 2009
  • Division for Cancer Epidemiology, Danish Cancer Society, Copenhagen. 2000 - 2003
  • Institute of Cancer Epidemiology, Danish Cancer Society, Laboratory of Molecular Biology, Statens Serum Institut, Denmark. 2003
  • Department of Obstetrics and Gynecology, The Gynecologic Clinic, The Juliane Marie Centre, Rigshospitalet, Denmark. 2002
  • Laboratory of Molecular Biology, Department of Clinical Biochemistry, State Serum Institute, Artillerivej 5, Denmark. 1999

References

  1. Proteomic biomarkers for overall and progression-free survival in ovarian cancer patients. Høgdall, E., Fung, E.T., Christensen, I.J., Yip, C., Nedergaard, L., Engelholm, S.A., Risum, S., Petri, A.L., Lundvall, L., Lomas, L., Høgdall, C. Proteomics. Clin. Appl (2010) [Pubmed]
  2. YKL-40 tissue expression and plasma levels in patients with ovarian cancer. Høgdall, E.V., Ringsholt, M., Høgdall, C.K., Christensen, I.J., Johansen, J.S., Kjaer, S.K., Blaakaer, J., Ostenfeld-Møller, L., Price, P.A., Christensen, L.H. BMC. Cancer (2009) [Pubmed]
  3. Protein expression levels of carcinoembryonic antigen (CEA) in Danish ovarian cancer patients: from the Danish 'MALOVA'ovarian cancer study. Høgdall, E.V., Christensen, L., Kjaer, S.K., Blaakaer, J., Jarle Christensen, I., Gayther, S., Jacobs, I.J., Høgdall, C.K. Pathology (2008) [Pubmed]
  4. Cancer antigen 125 and prognosis. Høgdall, E. Curr. Opin. Obstet. Gynecol. (2008) [Pubmed]
  5. Prognostic value of estrogen receptor and progesterone receptor tumor expression in Danish ovarian cancer patients: from the 'MALOVA' ovarian cancer study. Høgdall, E.V., Christensen, L., Høgdall, C.K., Blaakaer, J., Gayther, S., Jacobs, I.J., Christensen, I.J., Kjaer, S.K. Oncol. Rep. (2007) [Pubmed]
  6. CA125 expression pattern, prognosis and correlation with serum CA125 in ovarian tumor patients. From The Danish "MALOVA" Ovarian Cancer Study. Høgdall, E.V., Christensen, L., Kjaer, S.K., Blaakaer, J., Kjaerbye-Thygesen, A., Gayther, S., Jacobs, I.J., Høgdall, C.K. Gynecol. Oncol. (2007) [Pubmed]
  7. Expression level of Wilms tumor 1 (WT1) protein has limited prognostic value in epithelial ovarian cancer: from the Danish "MALOVA" ovarian cancer study. Høgdall, E.V., Christensen, L., Kjaer, S.K., Blaakaer, J., Christensen, I.J., Gayther, S., Jacobs, I.J., Høgdall, C.K. Gynecol. Oncol. (2007) [Pubmed]
  8. P53 mutations in tissue from Danish ovarian cancer patients: from the Danish "MALOVA" ovarian cancer study. Høgdall, E.V., Kjaer, S.K., Blaakaer, J., Christensen, L., Glud, E., Vuust, J., Høgdall, C.K. Gynecol. Oncol. (2006) [Pubmed]
  9. Loss of heterozygosity on the X chromosome is an independent prognostic factor in ovarian carcinoma: from the Danish "MALOVA" Ovarian Carcinoma Study. Høgdall, E.V., Ryan, A., Kjaer, S.K., Blaakaer, J., Christensen, L., Bock, J.E., Glud, E., Jacobs, I.J., Høgdall, C.K. Cancer (2004) [Pubmed]
  10. Distribution of HER-2 overexpression in ovarian carcinoma tissue and its prognostic value in patients with ovarian carcinoma: from the Danish MALOVA Ovarian Cancer Study. Høgdall, E.V., Christensen, L., Kjaer, S.K., Blaakaer, J., Bock, J.E., Glud, E., Nørgaard-Pedersen, B., Høgdall, C.K. Cancer (2003) [Pubmed]
  11. High plasma YKL-40 level in patients with ovarian cancer stage III is related to shorter survival. Høgdall, E.V., Johansen, J.S., Kjaer, S.K., Price, P.A., Christensen, L., Blaakaer, J., Bock, J.E., Glud, E., Høgdall, C.K. Oncol. Rep. (2003) [Pubmed]
  12. Evaluation of a polymorphism in intron 2 of the p53 gene in ovarian cancer patients. From the Danish "Malova" Ovarian Cancer Study. Høgdall, E.V., Kjaer, S.K., Glud, E., Christensen, L., Blaakaer, J., Vuust, J., Bock, J.E., Norgaard-Pedersen, B., Hogdall, C.K. Anticancer Res. (2003) [Pubmed]
  13. The prognostic value of pre-operative serum tetranectin, CA-125 and a combined index in women with primary ovarian cancer. Høgdall, C.K., Nørgaard-Pedersen, B., Mogensen, O. Anticancer Res. (2002) [Pubmed]
  14. Serum tetranectin is an independent prognostic marker in colorectal cancer and weakly correlated with plasma suPAR, plasma PAI-1 and serum CEA. Høgdall, C.K., Christensen, I.J., Stephens, R.W., Sørensen, S., Nørgaard-Pedersen, B., Nielsen, H.J. APMIS (2002) [Pubmed]
  15. Stability of YKL-40 concentration in blood samples. Høgdall, E.V., Johansen, J.S., Kjaer, S.K., Price, P.A., Blaakjaer, J., Høgdall, C.K. Scand. J. Clin. Lab. Invest. (2000) [Pubmed]
  16. OVX1 radioimmunoassay results are dependent on the method of sample collection and storage. Hogdall, E.V., Hogdall, C.K., Kjaer, S.K., Xu, F., Yu, Y., Bast, R.C., Blaakaer, J., Jacobs, I.J. Clin. Chem. (1999) [Pubmed]
 
WikiGenes - Universities